β57-Asp plays an essential role in the unique SDS stability of HLA-DQA1*0102/DQB1*0602 αβ protein dimer, the class II MHC allele associated with protection from insulin-dependent diabetes mellitus

Journal of Immunology

Volumn 165, Issue 6, 2000, Pages 3232-3238

  Ettinger, R A ^a   Liu, A W ^a   Nepom, G T ^a   Kwok, W W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARTIC ACID; DIMER; HLA DQ ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; TYROSINE;

ALLELE; ALLELISM; ANTIGEN EXPRESSION; ARTICLE; CODON; DISEASE PREDISPOSITION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC STABILITY; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0034665310     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.6.3232     Document Type: Article

References (32)

1. Immunology in diabetes: An update
2. HLA class II associations in insulin-dependent diabetes mellitus among Blacks, Caucasoids, and Japanese
3. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus
4. Effects of the second HLA-DQ haplotype on the association with childhood insulin-dependent diabetes mellitus
5. Exceptional stability of the HLA-DQA1*0102/DQB1*0602 αβ protein dimer, the class II MHC molecule associated with protection from insulin-dependent diabetes mellitus
6. The class II MHC I-A(g7) molecules from non-obese diabetic mice are poor peptide binders
7. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules
8. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells
9. Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome
10. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides
11. Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant
12. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants
13. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM
14. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM
15. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs
16. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site
17. HLA class II region nucleotide sequences, 1995
18. Bare lymphocyte syndrome: Altered HLA class II expression in B cell lines derived from two patients
19. Regulation of MHC class II genes: Lessons from a disease
20. HLA-DQw3-related determinants: Analysis of subunit and spatial relationships
21. HLA-DC antigens can serve as recognition elements for human cytotoxic T lymphocytes
22. Monoclonal antibody 1a3 recognizes a monomorphic epitope unique to DQ molecules
23. Two populations of Ia-like molecules on a human B cell line
24. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells
25. HLA-DQ polymorphisms are highly selective for peptide binding interactions
26. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
27. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3
28. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus
29. Analysis of critical residues of HLA-DQ6 molecules in insulin-dependent diabetes mellitus
30. MHC class-II molecules and autoimmunity
31. HLA-DQB1 codon 57 is critical for peptide binding and recognition
32. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase